Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | MGAM | O43451 | 1/20 | 0.46 |
| ▸ | SI | P14410 | 1/20 | 0.46 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9131994 | 0.98 | TDP1 (0.50) | TDP1L3MBTL1ALDH1A1GAAMGAM | |
| SCHEMBL18797 | 0.98 | TDP1 (0.50) | TDP1L3MBTL1ALDH1A1GAAMGAM | |
| Cyclohexane SCHEMBL28249403 | 0.98 | TDP1 (0.50) | TDP1L3MBTL1ALDH1A1GAAMGAM | |
| SCHEMBL2779505 | 0.98 | TDP1 (0.50) | TDP1L3MBTL1ALDH1A1GAAMGAM | |
| SCHEMBL26914635 | 0.98 | TDP1 (0.50) | TDP1L3MBTL1ALDH1A1GAAMGAM | |
| SCHEMBL25311355 | 0.98 | TDP1 (0.50) | TDP1L3MBTL1ALDH1A1GAAMGAM | |
| SCHEMBL9134377 | 0.98 | TDP1 (0.50) | TDP1L3MBTL1ALDH1A1GAAMGAM | |
| SCHEMBL29071102 | 0.96 | TDP1 (0.49) | TDP1L3MBTL1ALDH1A1GAAMGAM | |
| SCHEMBL1881523 | 0.96 | ALDH1A1 (0.46) | TDP1L3MBTL1ALDH1A1GAAMGAM | |
| Acetic Acid SCHEMBL17748838 | 0.92 | TDP1 (0.47) | TDP1L3MBTL1ALDH1A1GAAMGAM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 163 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117203313-A | 2, 4-dimethyloctan-2, 7-dien-4-ol as perfume | 西姆莱斯股份公司 | 2023-12-08 | — | — | CN | claimed |
| CN-116964182-A | 2, 6-trimethyl-pinan-2-ol as fragrance | 西姆莱斯股份公司 | 2023-10-27 | — | — | CN | claimed |
| EP-3416612-B1 | FRAGRANT MIXTURES CONTAINING ESTERS AND KETONES | SYMRISE AG (DE) | 2022-12-28 | — | — | EP | claimed |
| CN-109069378-B | Perfume mixture containing ester and ketone | 西姆莱斯股份公司 | 2022-10-11 | — | — | CN | claimed |
| US-20190136148-A1 | FRAGRANT MIXTURES CONTAINING ESTERS AND KETONES | SYMRISE AG (DE) | 2019-05-09 | — | — | US | claimed |
| EP-3416612-A1 | FRAGRANT MIXTURES CONTAINING ESTERS AND KETONES | Symrise AG (DE) | 2018-12-26 | — | — | EP | claimed |
| CN-109069378-A | spice mixture containing ester and ketone | 西姆莱斯股份公司 | 2018-12-21 | — | — | CN | claimed |
| WO-2017140336-A1 | FRAGRANT MIXTURES CONTAINING ESTERS AND KETONES | SYMRISE AG (DE) | 2017-08-24 | — | — | WO | claimed |
| US-5491167-A | INHIBITORS OF CHOLESTEROL BIOSYNTHESIS | SANKYO COMPANY, LIMITED (JP) | 1996-02-13 | — | — | US | claimed |
| CN-114555585-B | HPK1 inhibitors and uses thereof | 锐格药业公司 | 2025-02-11 | — | — | CN | disclosed |
| CN-117203313-A | 2, 4-dimethyloctan-2, 7-dien-4-ol as perfume | 西姆莱斯股份公司 | 2023-12-08 | — | — | CN | disclosed |
| CN-116964182-A | 2, 6-trimethyl-pinan-2-ol as fragrance | 西姆莱斯股份公司 | 2023-10-27 | — | — | CN | disclosed |
| EP-3416612-B1 | FRAGRANT MIXTURES CONTAINING ESTERS AND KETONES | SYMRISE AG (DE) | 2022-12-28 | — | — | EP | disclosed |
| EP-3416612-B1 | FRAGRANT MIXTURES CONTAINING ESTERS AND KETONES | SYMRISE AG (DE) | 2022-12-28 | — | — | EP | disclosed |
| US-4277498-A | Amides | BURROUGHS WELLCOME CO. (US) | 1981-07-07 | — | — | US | disclosed |
| US-4243672-A | CARDIOVASCULAR DISORDERS; CARDIOTONIC AGENTS | PFIZER INC. (US) | 1981-01-06 | — | — | US | disclosed |
| EP-0009326-A2 | Pyrrolyl keto and amino acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them | Pfizer Limited (GB) | 1980-04-02 | — | — | EP | disclosed |
| US-4167581-A | 1-ARYLOXY-3-(ACYLAMINO)ALKYLAMINO-2-PROPANOL ADRENERGIC BLOCKING, AGENTS AND CARDIAC STIMULANTS | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1979-09-11 | — | — | US | disclosed |
| US-4131685-A | ADRENERGIC BLOCKING AGENT, CARDIAC STIMULANT | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1978-12-26 | — | — | US | disclosed |
| US-4117014-A | PROSTAGLANDIN DERIVATIVES | ABBOTT LABORATORIES (US) | 1978-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190136148-A1 | FRAGRANT MIXTURES CONTAINING ESTERS AND KETONES | FASN, CETP, FAM120A | TDP1 4734/4885L3MBTL1 3105/4885ALDH1A1 651/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.